wayground logo

Free Printable Worksheets

NEW

Font size

S
M
L
XL
Worksheets

Pharmacokinetics, Pharmacodynamics Test

Total questions: 50

Worksheet time: 50mins

Name
Class
Date
1.

A nurse administers an IV antibiotic to a patient. After 5 hours, the drug concentration has decreased to 25% of the initial value. What concept best explains this observation?

a)

First-order kinetics

b)

Zero-order kinetics

c)

Saturation kinetics

d)

Therapeutic window

2.

A patient with cirrhosis shows a prolonged half-life for a prescribed medication. What is the most likely explanation?

a)

Increased metabolism

b)

Decreased hepatic clearance

c)

Enhanced renal excretion

d)

Decreased drug absorption

3.

A nurse is caring for a patient receiving morphine. She notes that the drug is metabolized by conjugation. What phase of metabolism is primarily involved?

a)

Phase I oxidation

b)

Phase II conjugation

c)

Phase I reduction

d)

Cytochrome inhibition

4.

A nursing student learns that a drug is eliminated via zero-order kinetics. What is the best interpretation of this?

a)

A fixed percentage is eliminated per hour

b)

A fixed amount is eliminated per hour

c)

Elimination increases with concentration

d)

Half-life remains constant regardless of dose

5.

A patient with renal failure is prescribed digoxin. Which pharmacokinetic parameter should the nurse monitor closely?

a)

Volume of distribution

b)

Protein binding

c)

Clearance

d)

Bioavailability

6.

A nurse explains to a patient that a loading dose of a drug is given. What is the main purpose of this loading dose?

a)

To achieve therapeutic levels rapidly

b)

To improve drug metabolism

c)

To reduce toxicity risk

d)

To enhance drug excretion

7.

A patient receiving phenytoin shows signs of toxicity despite a normal dose. Which kinetic principle likely explains this?

a)

First-order kinetics

b)

Linear kinetics

c)

Zero-order kinetics

d)

Renal excretion variability

8.

After administering a drug, the nurse observes that the plasma concentration rises and reaches a plateau after several doses. What is this plateau called?

a)

Maximum effect

b)

Drug saturation

c)

Steady-state concentration

d)

Therapeutic range

9.

A nurse is giving rifampin with antiretroviral therapy. What is the likely pharmacokinetic consequence?

a)

Increased plasma drug levels

b)

Decreased effectiveness due to enzyme induction

c)

No effect on drug levels

d)

Enhanced drug absorption

10.

A patient is prescribed a drug that is a substrate of CYP3A4. What advice should the nurse give regarding grapefruit juice?

a)

It helps drug elimination

b)

Avoid it as it may increase drug toxicity

c)

It enhances absorption safely

d)

It prevents first-pass metabolism

11.

A nurse administers oral medication to a patient. She explains that some of the drug is lost during first-pass metabolism. Where does this primarily occur?

a)

Kidney

b)

Brain

c)

Pancreas

d)

Liver

12.

In a case of phenobarbital overdose, what nursing intervention helps enhance drug excretion?

a)

Alkalinization of urine

b)

Acidification of urine

c)

Increasing lipid solubility

d)

Blocking CYP450

13.

A nurse adjusts the dose of a lipid-soluble drug for a patient with high body fat. What pharmacokinetic factor is being considered?

a)

Volume of distribution

b)

Renal clearance

c)

Hepatic metabolism

d)

Protein binding

14.

A patient is given a highly protein-bound drug. What will likely happen if the patient has low albumin levels?

a)

Decreased free drug

b)

Faster elimination

c)

Increased free drug concentration

d)

Slower onset of action

15.

A nurse needs to administer a drug with a narrow therapeutic window. What is the safest approach?

a)

Give a higher dose initially

b)

Monitor drug levels closely

c)

Use alternative routes

d)

Extend dosing intervals

16.

A patient taking codeine reports no pain relief. The nurse suspects the issue lies in metabolism. Which enzyme is likely involved?

a)

CYP3A4

b)

CYP2D6

c)

CYP2E1

d)

CYP1A2

17.

A nurse administers a drug every 12 hours. The drug has a half-life of 12 hours. What will happen to the drug concentration over time?

a)

It will stay the same

b)

It will accumulate and reach steady state

c)

It will be eliminated immediately

d)

It will continuously rise without limit

18.

A nurse explains that a drug is eliminated by first-order kinetics. What does this mean?

a)

A fixed dose is eliminated every hour

b)

A constant fraction is eliminated per time

c)

Elimination is independent of drug level

d)

The drug is not eliminated at all

19.

A nurse is calculating the maintenance dose for a drug. Which parameter is NOT needed?

a)

Target plasma concentration

b)

Drug clearance

c)

Bioavailability

d)

Half-life

20.

After stopping a continuous drug infusion, how long will it take for the drug to be almost completely eliminated (about 95%)?

a)

1 half-life

b)

2 half-lives

c)

5 half-lives

d)

10 half-lives

21.

A nurse sees that a drug has a very short half-life. What does this mean for dosing?

a)

More frequent dosing is required

b)

A loading dose is unnecessary

c)

The drug is not absorbed well

d)

It can be dosed once daily

22.

A drug metabolized by CYP2C19 is given to a poor metabolizer. What outcome is most likely?

a)

Reduced efficacy or increased toxicity

b)

Enhanced clearance

c)

Decreased plasma levels

d)

Faster therapeutic effect

23.

A nurse is administering an oral drug that has poor bioavailability. Which factor contributes most to this issue?

a)

First-pass metabolism

b)

High water solubility

c)

Short half-life

d)

Increased renal excretion

24.

In a patient with heart failure and low hepatic perfusion, what is the expected effect on drug metabolism?

a)

Decreased drug clearance

b)

Increased drug half-life

c)

Increased absorption

d)

No change in pharmacokinetics

25.

A nurse is reviewing the effect of enzyme inducers like phenobarbital on drug levels. What is the expected result?

a)

Increased plasma concentration

b)

Decreased therapeutic effect

c)

Longer half-life

d)

Reduced renal excretion

26.

A nurse is administering a medication that is a full agonist. What effect should the nurse anticipate?

a)

It will bind to the receptor and produce a maximal biologic response.

b)

It will bind to the receptor but produce no biologic response.

c)

It will only partially activate the receptor.

d)

It will inhibit the receptor activity below the baseline level.

27.

A patient is prescribed phenylephrine, a full agonist at α1-adrenoceptors. What is the expected effect on blood pressure?

a)

Increased blood pressure due to vasoconstriction.

b)

Decreased blood pressure due to vasodilation

c)

No change in blood pressure.

d)

Fluctuating blood pressure with no predictable response.

28.

A nurse is caring for a patient receiving aripiprazole, a partial dopamine agonist. Which best describes its therapeutic advantage?

a)

It fully blocks dopamine and reduces all side effects.

b)

It modulates dopamine activity, reducing overactivity and enhancing underactivity.

c)

It stimulates dopamine receptors to the maximum extent.

d)

It increases dopamine in all brain pathways equally.

29.

A patient receives a medication that binds to a receptor and reduces receptor activity below baseline. The nurse recognizes this drug as:

a)

A full agonist

b)

A partial agonist

c)

An inverse agonist

d)

A competitive antagonist

30.

A nurse is reviewing a medication that binds to a receptor without activating it and prevents agonist binding. What type of drug is this?

a)

Inverse agonist

b)

Competitive antagonist

c)

Allosteric agonist

d)

Partial agonist

31.

A patient is taking terazosin, a competitive antagonist. Which change would the nurse expect on the dose-response curve of an agonist?

a)

Decreased Emax

b)

Shift to the left

c)

Increased EC50 without change in Emax

d)

Irreversible inhibition of the receptor

32.

The nurse administers a noncompetitive antagonist. What should the nurse expect in terms of drug efficacy?

a)

A decrease in the maximal response (Emax)

b)

An increase in EC50 with no change in Emax

c)

A reversible inhibition of agonist binding

d)

A short duration of drug-receptor binding

33.

What is the expected result of an allosteric antagonist binding to a receptor?

a)

Increased agonist binding

b)

Decreased Emax without changing EC50

c)

Decreased EC50

d)

Increased receptor activation

34.

Which type of antagonism involves activation of a different receptor to produce an opposing physiologic effect?

a)

Allosteric antagonism

b)

Functional (physiologic) antagonism

c)

Competitive antagonism

d)

Irreversible antagonism

35.

Epinephrine is used to counteract histamine-induced bronchoconstriction. This is an example of:

a)

Allosteric antagonism

b)

Competitive antagonism

c)

Functional (physiologic) antagonism

d)

Inverse agonism

36.

A nurse explains to a student that partial agonists may act as antagonists in the presence of full agonists Because:

a)

They increase the number of active receptors.

b)

They have higher efficacy.

c)

They displace full agonists and reduce the maximal response.

d)

They increase intrinsic activity beyond that of full agonists.

37.

The nurse is monitoring a patient taking two drugs: one is a full agonist and the other is a partial agonist for the same receptor. What outcome is expected?

a)

Enhanced full agonist activity

b)

Inhibition of the partial agonist by the full agonist

c)

Reduced overall receptor response

d)

No interaction occurs

38.

A medication has an intrinsic activity of zero and blocks the action of an agonist. What type of drug is it?

a)

Inverse agonist

b)

Antagonist

c)

Full agonist

d)

Partial agonist

39.

A nurse understands that inverse agonists differ from antagonists Because:

a)

They activate more receptors.

b)

They have no effect on receptor activity.

c)

They reduce receptor activity below baseline.

d)

They compete reversibly with agonists.

40.

Which property does not change when a competitive antagonist is administered with an agonist?

a)

Drug potency

b)

EC50 value

c)

Maximum efficacy (Emax)

d)

Required drug concentration

41.

Which scenario best illustrates the concept of therapeutic index (TI)?

a)

A drug with a TI of 1 is very safe.

b)

A drug with a high TI has a wider margin between effective and toxic doses.

c)

Drugs with low TI can be given freely without monitoring.

d)

TI is unrelated to drug safety.

42.

Which drug would require careful dose monitoring due to a low therapeutic index?

a)

Warfarin

b)

Penicillin

c)

Ibuprofen

d)

Acetaminophen

43.

A patient receives penicillin for an infection. The nurse recognizes this as a safe drug because:

a)

It is not absorbed systemically.

b)

It binds irreversibly to its target.

c)

It has a large therapeutic index.

d)

It is metabolized slowly by the liver.

44.

What happens to the dose-response curve in the presence of an irreversible antagonist?

a)

Rightward shift with no change in Emax

b)

Decrease in Emax with no shift in EC50

c)

No change in the curve

d)

Leftward shift with increased potency

45.

A nurse administering a drug that demonstrates constitutive receptor activity should know that:

a)

Only agonists can activate the receptor.

b)

Receptors are inactive without drug binding.

c)

Receptors can spontaneously activate without ligands.

d)

Inverse agonists will further enhance activity.

46.

Which best describes a quantal dose-response relationship?

a)

The effect is graded and varies in intensity.

b)

The effect either occurs or does not in individuals.

c)

It measures the rate of receptor binding.

d)

It is used only for pediatric dosing.

47.

During a medication review, the nurse identifies that a drug has a high ED50. What does this imply?

a)

It is highly toxic.

b)

It is rapidly absorbed.

c)

It requires a larger dose to achieve 50% effectiveness.

d)

It cannot be used with other medications.

48.

A drug trial shows the TD50 of a drug is close to the ED50. The nurse understands this means:

a)

The drug has a narrow therapeutic index and requires close monitoring.

b)

The drug is very safe.

c)

The drug is not effective at all.

d)

The drug has no side effects.

49.

A drug has a TI of 10. What does this indicate?

a)

The drug is extremely toxic.

b)

The drug has a wide margin of safety.

c)

The drug is ineffective in most people.

d)

The drug should only be given in hospitals.

50.

Why is it important for nurses to understand pharmacodynamic principles like receptor activity, agonism, and antagonism?

a)

To know how to write prescriptions

b)

To anticipate drug effects and prevent adverse reactions

c)

To determine pricing and availability

d)

To manage patient insurance claims